A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines.
Putong, Nimfa;
Agrupis, Kristal An;
Villanueva, Annavi Marie;
Suzuki, Shuichi;
Sayo, Ana Ria;
Dimaano, Efren;
de Guzman, Ferdinand;
Teaño, Ruel;
Salazar, Mary Jane;
Evangelista, Jan Wendzl;
+5 more...Dimapilis, Alexis;
Villarama, Jose Benito;
Ariyoshi, Koya;
Takahashi, Kensuke;
Smith, Chris;
(2022)
A call to protect non-clinical frontliners in the fight against COVID-19: evidence from a seroprevalence study in the Philippines.
The Lancet Regional Health - Western Pacific, 18.
100353-.
ISSN 2666-6065
DOI: https://doi.org/10.1016/j.lanwpc.2021.100353
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Since the COVID-19 pandemic started in 2020, healthcare workers (HCW) and other hospital personnel have been regarded as “frontliners”, and at increased risk of SARS-CoV-2 infection compared to the general population. As such, testing only symptomatic individuals or regular testing of HCWs who directly attend to COVID-19 patients or specimens may underestimate the extent of infection, and actual SARS-CoV-2 seroprevalence. Because of this, the World Health Organization has called for seroepidemiological surveys to assess the extent of infection amongst HCW and other populations to provide timely estimates of COVID-19 virus infection severity and inform public health responses and evidence-based policy decisions.